Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial - The Lancet

Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association

Pharmacokinetics of the most commonly used antihypertensive drugs throughout pregnancy methyldopa, labetalol, and nifedipine: a systematic review. - Abstract - Europe PMC

Antihypertensive drug therapy for mild to moderate hypertension during pregnancy - Abalos, E - 2018

Severe Pre-Eclampsia with Partial Hellp Syndrome in Multigravida Preterm Pregnancy

Effectiveness of nifedipine, labetalol, and

Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial - The Lancet

Comparative maternal outcomes of oral nifedipine and intravenous labetalol for severe hypertension during pregnancy: an open label randomized controlled trial. - Document - Gale Academic OneFile

The Lancet, 21 September 2019, Volume 394, Issue 10203, Pages 979-1112

IJERPH, Free Full-Text

PDF) Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open- label, randomised controlled trial

Actualizacion de La Preeclampsia, PDF, Hypertension

Maternal Medicine (Section 4) - The EBCOG Postgraduate Textbook of Obstetrics & Gynaecology